almotriptan: Clinical Trials

8 trials of almotriptan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 terminated, 1 unknown. 6 Phase 4, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 46Completed 4, Terminated 1, Unknown 1
Phase 32Completed 2

Follow almotriptan: new trials by email Literature Review of almotriptan trials Research Report on almotriptan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine
Almotriptan 12.5 Mg Oral Tablet, Ubrogepant 50Mg Tab - Migraine With Aura, Migraine Without Aura
Phase 4TerminatedMessoud Ashina, MD82022-06-302025-05-31
Detoxification and Treatment of Subjects With Medication Overuse Headache
Almotriptan, Topiramate - Analgesic Rebound Headache
Phase 4UnknownThe New England Center for Headache, P.C.602007-01-012007-02-08
A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches
Almotriptan Malate - Migraine
Phase 3CompletedJanssen-Ortho LLC4472005-12-012014-02-21
Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
topiramate; almotriptan malate - Migraine, Classic Migraine
Phase 4CompletedJanssen-Ortho LLC4062005-06-012011-05-17
A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache
almotriptan malate - Migraine
Phase 4CompletedJanssen-Ortho LLC3782004-11-012011-05-17
The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain
almotriptan malate - Migraine
Phase 4CompletedOrtho-McNeil Neurologics, Inc.14502004-06-012011-05-19
Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers
almotriptan or pseudoephedrine - Migraine, Sinusitis
Phase 4CompletedClinvest502004-05-012009-05-06
A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents
almotriptan malate - Migraine
Phase 3CompletedJanssen-Ortho LLC8662003-07-012011-05-17

Conditions studied

Migraine Disorders (6)  ·  Headache (3)  ·  Epilepsy (2)  ·  Migraine with Aura (2)  ·  Migraine without Aura (2)  ·  Pain (2)  ·  Headache Disorders, Secondary (1)  ·  Prescription Drug Overuse (1)  ·  Rhinosinusitis (1)  ·  Sinusitis (1)

Sponsors

Janssen-Ortho LLC (4)  ·  Clinvest (1)  ·  Messoud Ashina, MD (1)  ·  Ortho-McNeil Neurologics, Inc. (1)  ·  The New England Center for Headache, P.C. (1)

Countries

United States (3)  ·  Denmark (1)

Top investigators

Fred D Sheftell, M.D. (1)  ·  Messoud Ashina, Prof. (1)  ·  Ortho McNeil Neurologics, Inc. Clinical Trial (1)  ·  Roger K Cady, MD (1)

Results publications

PMID 17300358, PMID 17445101, PMID 18484981